A new dimension in newborn screening.

to improve newborn health.

Newborn screening is a key paediatric tool for the early detection of treatable congenital diseases. Introducing genomic newborn screening could significantly improve the detection and treatment of serious paediatric diseases.

9 communities

The pilot is taking place in Andalusia, Aragon, Asturias, Catalonia, Galicia, La Rioja, Madrid, Murcia and Valencia.

80%

Over 80% of rare diseases have a genetic origin.

44diseases

Traditional screening in Spain detects between 11 and 44 diseases

We are more than

70

specialists

We can detect more than

300

rare diseases

Sequencing analysis
will allow studying more

600

Genes

What is CRINGENES?

A key tool in detecting paediatric diseases before symptoms appear.

Traditional screening detects between 11 and 44 diseases. Through genomic analysis this limit could be surpassed since 80% of all rare diseases have a genetic origin.

Explore the Project

Get to know the people, the data, and the advances that make this project possible.

CRINGENES brings together professionals from all over Spain, analyzes hundreds of genes linked to rare diseases and shares its results with the scientific community. A pioneering initiative that unites science, health and prevention from birth.

Transforming prevention into health from day one.

CRINGENES brings together professionals from all over Spain, analyzes hundreds of genes linked to rare diseases and shares its results with the scientific community. A pioneering initiative that unites science, health and prevention from birth.